nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—Urethral disorder—Methotrexate—testicular cancer	0.000472	0.000472	CcSEcCtD
Cidofovir—Weight decreased—Doxorubicin—testicular cancer	0.000471	0.000471	CcSEcCtD
Cidofovir—Sinusitis—Epirubicin—testicular cancer	0.000471	0.000471	CcSEcCtD
Cidofovir—Feeling abnormal—Etoposide—testicular cancer	0.000471	0.000471	CcSEcCtD
Cidofovir—Hyperglycaemia—Doxorubicin—testicular cancer	0.00047	0.00047	CcSEcCtD
Cidofovir—Nausea—Dactinomycin—testicular cancer	0.000469	0.000469	CcSEcCtD
Cidofovir—Pneumonia—Doxorubicin—testicular cancer	0.000467	0.000467	CcSEcCtD
Cidofovir—Gastrointestinal pain—Etoposide—testicular cancer	0.000467	0.000467	CcSEcCtD
Cidofovir—Visual impairment—Methotrexate—testicular cancer	0.000464	0.000464	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00046	0.00046	CcSEcCtD
Cidofovir—Vomiting—Ifosfamide—testicular cancer	0.00046	0.00046	CcSEcCtD
Cidofovir—Hypersensitivity—Cisplatin—testicular cancer	0.000459	0.000459	CcSEcCtD
Cidofovir—Renal failure—Doxorubicin—testicular cancer	0.000456	0.000456	CcSEcCtD
Cidofovir—Rash—Ifosfamide—testicular cancer	0.000456	0.000456	CcSEcCtD
Cidofovir—Dermatitis—Ifosfamide—testicular cancer	0.000455	0.000455	CcSEcCtD
Cidofovir—Erythema multiforme—Methotrexate—testicular cancer	0.000455	0.000455	CcSEcCtD
Cidofovir—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000455	0.000455	CcSEcCtD
Cidofovir—Urticaria—Etoposide—testicular cancer	0.000454	0.000454	CcSEcCtD
Cidofovir—Jaundice—Doxorubicin—testicular cancer	0.000453	0.000453	CcSEcCtD
Cidofovir—Stomatitis—Doxorubicin—testicular cancer	0.000453	0.000453	CcSEcCtD
Cidofovir—Rhinitis—Epirubicin—testicular cancer	0.000452	0.000452	CcSEcCtD
Cidofovir—Body temperature increased—Etoposide—testicular cancer	0.000451	0.000451	CcSEcCtD
Cidofovir—Abdominal pain—Etoposide—testicular cancer	0.000451	0.000451	CcSEcCtD
Cidofovir—Conjunctivitis—Doxorubicin—testicular cancer	0.000451	0.000451	CcSEcCtD
Cidofovir—Urinary tract infection—Doxorubicin—testicular cancer	0.000451	0.000451	CcSEcCtD
Cidofovir—Hepatitis—Epirubicin—testicular cancer	0.00045	0.00045	CcSEcCtD
Cidofovir—Eye disorder—Methotrexate—testicular cancer	0.00045	0.00045	CcSEcCtD
Cidofovir—Tinnitus—Methotrexate—testicular cancer	0.000449	0.000449	CcSEcCtD
Cidofovir—Asthenia—Cisplatin—testicular cancer	0.000447	0.000447	CcSEcCtD
Cidofovir—Pharyngitis—Epirubicin—testicular cancer	0.000447	0.000447	CcSEcCtD
Cidofovir—Sweating—Doxorubicin—testicular cancer	0.000445	0.000445	CcSEcCtD
Cidofovir—Urinary tract disorder—Epirubicin—testicular cancer	0.000445	0.000445	CcSEcCtD
Cidofovir—Oedema peripheral—Epirubicin—testicular cancer	0.000444	0.000444	CcSEcCtD
Cidofovir—Haematuria—Doxorubicin—testicular cancer	0.000443	0.000443	CcSEcCtD
Cidofovir—Urethral disorder—Epirubicin—testicular cancer	0.000442	0.000442	CcSEcCtD
Cidofovir—Epistaxis—Doxorubicin—testicular cancer	0.000438	0.000438	CcSEcCtD
Cidofovir—Angiopathy—Methotrexate—testicular cancer	0.000437	0.000437	CcSEcCtD
Cidofovir—Sinusitis—Doxorubicin—testicular cancer	0.000436	0.000436	CcSEcCtD
Cidofovir—Visual impairment—Epirubicin—testicular cancer	0.000434	0.000434	CcSEcCtD
Cidofovir—Mediastinal disorder—Methotrexate—testicular cancer	0.000434	0.000434	CcSEcCtD
Cidofovir—Chills—Methotrexate—testicular cancer	0.000432	0.000432	CcSEcCtD
Cidofovir—Nausea—Ifosfamide—testicular cancer	0.000429	0.000429	CcSEcCtD
Cidofovir—Diarrhoea—Cisplatin—testicular cancer	0.000426	0.000426	CcSEcCtD
Cidofovir—Erythema multiforme—Epirubicin—testicular cancer	0.000426	0.000426	CcSEcCtD
Cidofovir—Alopecia—Methotrexate—testicular cancer	0.000425	0.000425	CcSEcCtD
Cidofovir—Eye disorder—Epirubicin—testicular cancer	0.000421	0.000421	CcSEcCtD
Cidofovir—Hypersensitivity—Etoposide—testicular cancer	0.000421	0.000421	CcSEcCtD
Cidofovir—Tinnitus—Epirubicin—testicular cancer	0.00042	0.00042	CcSEcCtD
Cidofovir—Flushing—Epirubicin—testicular cancer	0.000418	0.000418	CcSEcCtD
Cidofovir—Rhinitis—Doxorubicin—testicular cancer	0.000418	0.000418	CcSEcCtD
Cidofovir—Hepatitis—Doxorubicin—testicular cancer	0.000417	0.000417	CcSEcCtD
Cidofovir—Pharyngitis—Doxorubicin—testicular cancer	0.000414	0.000414	CcSEcCtD
Cidofovir—Urinary tract disorder—Doxorubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Cidofovir—Oedema peripheral—Doxorubicin—testicular cancer	0.000411	0.000411	CcSEcCtD
Cidofovir—Dysgeusia—Methotrexate—testicular cancer	0.00041	0.00041	CcSEcCtD
Cidofovir—Asthenia—Etoposide—testicular cancer	0.00041	0.00041	CcSEcCtD
Cidofovir—Angiopathy—Epirubicin—testicular cancer	0.000409	0.000409	CcSEcCtD
Cidofovir—Urethral disorder—Doxorubicin—testicular cancer	0.000409	0.000409	CcSEcCtD
Cidofovir—Mediastinal disorder—Epirubicin—testicular cancer	0.000406	0.000406	CcSEcCtD
Cidofovir—Back pain—Methotrexate—testicular cancer	0.000405	0.000405	CcSEcCtD
Cidofovir—Chills—Epirubicin—testicular cancer	0.000404	0.000404	CcSEcCtD
Cidofovir—Pruritus—Etoposide—testicular cancer	0.000404	0.000404	CcSEcCtD
Cidofovir—Visual impairment—Doxorubicin—testicular cancer	0.000402	0.000402	CcSEcCtD
Cidofovir—Alopecia—Epirubicin—testicular cancer	0.000398	0.000398	CcSEcCtD
Cidofovir—Vomiting—Cisplatin—testicular cancer	0.000396	0.000396	CcSEcCtD
Cidofovir—Erythema multiforme—Doxorubicin—testicular cancer	0.000394	0.000394	CcSEcCtD
Cidofovir—Rash—Cisplatin—testicular cancer	0.000393	0.000393	CcSEcCtD
Cidofovir—Dermatitis—Cisplatin—testicular cancer	0.000393	0.000393	CcSEcCtD
Cidofovir—Diarrhoea—Etoposide—testicular cancer	0.000391	0.000391	CcSEcCtD
Cidofovir—Eye disorder—Doxorubicin—testicular cancer	0.00039	0.00039	CcSEcCtD
Cidofovir—Ill-defined disorder—Methotrexate—testicular cancer	0.000389	0.000389	CcSEcCtD
Cidofovir—Tinnitus—Doxorubicin—testicular cancer	0.000389	0.000389	CcSEcCtD
Cidofovir—Anaemia—Methotrexate—testicular cancer	0.000387	0.000387	CcSEcCtD
Cidofovir—Flushing—Doxorubicin—testicular cancer	0.000387	0.000387	CcSEcCtD
Cidofovir—Flatulence—Epirubicin—testicular cancer	0.000386	0.000386	CcSEcCtD
Cidofovir—Tension—Epirubicin—testicular cancer	0.000385	0.000385	CcSEcCtD
Cidofovir—Dysgeusia—Epirubicin—testicular cancer	0.000384	0.000384	CcSEcCtD
Cidofovir—Nervousness—Epirubicin—testicular cancer	0.000381	0.000381	CcSEcCtD
Cidofovir—Back pain—Epirubicin—testicular cancer	0.000379	0.000379	CcSEcCtD
Cidofovir—Angiopathy—Doxorubicin—testicular cancer	0.000378	0.000378	CcSEcCtD
Cidofovir—Malaise—Methotrexate—testicular cancer	0.000378	0.000378	CcSEcCtD
Cidofovir—Dizziness—Etoposide—testicular cancer	0.000378	0.000378	CcSEcCtD
Cidofovir—Muscle spasms—Epirubicin—testicular cancer	0.000377	0.000377	CcSEcCtD
Cidofovir—Vertigo—Methotrexate—testicular cancer	0.000376	0.000376	CcSEcCtD
Cidofovir—Mediastinal disorder—Doxorubicin—testicular cancer	0.000376	0.000376	CcSEcCtD
Cidofovir—Leukopenia—Methotrexate—testicular cancer	0.000375	0.000375	CcSEcCtD
Cidofovir—Chills—Doxorubicin—testicular cancer	0.000374	0.000374	CcSEcCtD
Cidofovir—Nausea—Cisplatin—testicular cancer	0.00037	0.00037	CcSEcCtD
Cidofovir—Alopecia—Doxorubicin—testicular cancer	0.000368	0.000368	CcSEcCtD
Cidofovir—Cough—Methotrexate—testicular cancer	0.000366	0.000366	CcSEcCtD
Cidofovir—Ill-defined disorder—Epirubicin—testicular cancer	0.000364	0.000364	CcSEcCtD
Cidofovir—Convulsion—Methotrexate—testicular cancer	0.000363	0.000363	CcSEcCtD
Cidofovir—Vomiting—Etoposide—testicular cancer	0.000363	0.000363	CcSEcCtD
Cidofovir—Anaemia—Epirubicin—testicular cancer	0.000362	0.000362	CcSEcCtD
Cidofovir—Agitation—Epirubicin—testicular cancer	0.00036	0.00036	CcSEcCtD
Cidofovir—Rash—Etoposide—testicular cancer	0.00036	0.00036	CcSEcCtD
Cidofovir—Dermatitis—Etoposide—testicular cancer	0.00036	0.00036	CcSEcCtD
Cidofovir—Headache—Etoposide—testicular cancer	0.000358	0.000358	CcSEcCtD
Cidofovir—Flatulence—Doxorubicin—testicular cancer	0.000358	0.000358	CcSEcCtD
Cidofovir—Chest pain—Methotrexate—testicular cancer	0.000357	0.000357	CcSEcCtD
Cidofovir—Arthralgia—Methotrexate—testicular cancer	0.000357	0.000357	CcSEcCtD
Cidofovir—Myalgia—Methotrexate—testicular cancer	0.000357	0.000357	CcSEcCtD
Cidofovir—Tension—Doxorubicin—testicular cancer	0.000356	0.000356	CcSEcCtD
Cidofovir—Dysgeusia—Doxorubicin—testicular cancer	0.000355	0.000355	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000354	0.000354	CcSEcCtD
Cidofovir—Malaise—Epirubicin—testicular cancer	0.000354	0.000354	CcSEcCtD
Cidofovir—Discomfort—Methotrexate—testicular cancer	0.000352	0.000352	CcSEcCtD
Cidofovir—Nervousness—Doxorubicin—testicular cancer	0.000352	0.000352	CcSEcCtD
Cidofovir—Vertigo—Epirubicin—testicular cancer	0.000352	0.000352	CcSEcCtD
Cidofovir—Syncope—Epirubicin—testicular cancer	0.000352	0.000352	CcSEcCtD
Cidofovir—Leukopenia—Epirubicin—testicular cancer	0.000351	0.000351	CcSEcCtD
Cidofovir—Back pain—Doxorubicin—testicular cancer	0.000351	0.000351	CcSEcCtD
Cidofovir—Muscle spasms—Doxorubicin—testicular cancer	0.000349	0.000349	CcSEcCtD
Cidofovir—Confusional state—Methotrexate—testicular cancer	0.000345	0.000345	CcSEcCtD
Cidofovir—Loss of consciousness—Epirubicin—testicular cancer	0.000345	0.000345	CcSEcCtD
Cidofovir—Cough—Epirubicin—testicular cancer	0.000342	0.000342	CcSEcCtD
Cidofovir—Anaphylactic shock—Methotrexate—testicular cancer	0.000342	0.000342	CcSEcCtD
Cidofovir—Convulsion—Epirubicin—testicular cancer	0.00034	0.00034	CcSEcCtD
Cidofovir—Infection—Methotrexate—testicular cancer	0.00034	0.00034	CcSEcCtD
Cidofovir—Nausea—Etoposide—testicular cancer	0.000339	0.000339	CcSEcCtD
Cidofovir—Hypertension—Epirubicin—testicular cancer	0.000339	0.000339	CcSEcCtD
Cidofovir—Ill-defined disorder—Doxorubicin—testicular cancer	0.000337	0.000337	CcSEcCtD
Cidofovir—Nervous system disorder—Methotrexate—testicular cancer	0.000335	0.000335	CcSEcCtD
Cidofovir—Anaemia—Doxorubicin—testicular cancer	0.000335	0.000335	CcSEcCtD
Cidofovir—Thrombocytopenia—Methotrexate—testicular cancer	0.000335	0.000335	CcSEcCtD
Cidofovir—Arthralgia—Epirubicin—testicular cancer	0.000334	0.000334	CcSEcCtD
Cidofovir—Chest pain—Epirubicin—testicular cancer	0.000334	0.000334	CcSEcCtD
Cidofovir—Myalgia—Epirubicin—testicular cancer	0.000334	0.000334	CcSEcCtD
Cidofovir—Agitation—Doxorubicin—testicular cancer	0.000333	0.000333	CcSEcCtD
Cidofovir—Anxiety—Epirubicin—testicular cancer	0.000333	0.000333	CcSEcCtD
Cidofovir—Skin disorder—Methotrexate—testicular cancer	0.000332	0.000332	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000332	0.000332	CcSEcCtD
Cidofovir—Hyperhidrosis—Methotrexate—testicular cancer	0.000331	0.000331	CcSEcCtD
Cidofovir—Discomfort—Epirubicin—testicular cancer	0.00033	0.00033	CcSEcCtD
Cidofovir—Malaise—Doxorubicin—testicular cancer	0.000327	0.000327	CcSEcCtD
Cidofovir—Dry mouth—Epirubicin—testicular cancer	0.000327	0.000327	CcSEcCtD
Cidofovir—Vertigo—Doxorubicin—testicular cancer	0.000326	0.000326	CcSEcCtD
Cidofovir—Anorexia—Methotrexate—testicular cancer	0.000326	0.000326	CcSEcCtD
Cidofovir—Syncope—Doxorubicin—testicular cancer	0.000325	0.000325	CcSEcCtD
Cidofovir—Leukopenia—Doxorubicin—testicular cancer	0.000325	0.000325	CcSEcCtD
Cidofovir—Confusional state—Epirubicin—testicular cancer	0.000323	0.000323	CcSEcCtD
Cidofovir—Anaphylactic shock—Epirubicin—testicular cancer	0.00032	0.00032	CcSEcCtD
Cidofovir—Oedema—Epirubicin—testicular cancer	0.00032	0.00032	CcSEcCtD
Cidofovir—Hypotension—Methotrexate—testicular cancer	0.00032	0.00032	CcSEcCtD
Cidofovir—Loss of consciousness—Doxorubicin—testicular cancer	0.000319	0.000319	CcSEcCtD
Cidofovir—Infection—Epirubicin—testicular cancer	0.000318	0.000318	CcSEcCtD
Cidofovir—Cough—Doxorubicin—testicular cancer	0.000317	0.000317	CcSEcCtD
Cidofovir—Shock—Epirubicin—testicular cancer	0.000315	0.000315	CcSEcCtD
Cidofovir—Convulsion—Doxorubicin—testicular cancer	0.000314	0.000314	CcSEcCtD
Cidofovir—Nervous system disorder—Epirubicin—testicular cancer	0.000314	0.000314	CcSEcCtD
Cidofovir—Thrombocytopenia—Epirubicin—testicular cancer	0.000313	0.000313	CcSEcCtD
Cidofovir—Hypertension—Doxorubicin—testicular cancer	0.000313	0.000313	CcSEcCtD
Cidofovir—Tachycardia—Epirubicin—testicular cancer	0.000312	0.000312	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000312	0.000312	CcSEcCtD
Cidofovir—Skin disorder—Epirubicin—testicular cancer	0.000311	0.000311	CcSEcCtD
Cidofovir—Hyperhidrosis—Epirubicin—testicular cancer	0.000309	0.000309	CcSEcCtD
Cidofovir—Insomnia—Methotrexate—testicular cancer	0.000309	0.000309	CcSEcCtD
Cidofovir—Myalgia—Doxorubicin—testicular cancer	0.000309	0.000309	CcSEcCtD
Cidofovir—Chest pain—Doxorubicin—testicular cancer	0.000309	0.000309	CcSEcCtD
Cidofovir—Arthralgia—Doxorubicin—testicular cancer	0.000309	0.000309	CcSEcCtD
Cidofovir—Anxiety—Doxorubicin—testicular cancer	0.000308	0.000308	CcSEcCtD
Cidofovir—Paraesthesia—Methotrexate—testicular cancer	0.000307	0.000307	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000307	0.000307	CcSEcCtD
Cidofovir—Discomfort—Doxorubicin—testicular cancer	0.000305	0.000305	CcSEcCtD
Cidofovir—Anorexia—Epirubicin—testicular cancer	0.000305	0.000305	CcSEcCtD
Cidofovir—Dyspnoea—Methotrexate—testicular cancer	0.000305	0.000305	CcSEcCtD
Cidofovir—Somnolence—Methotrexate—testicular cancer	0.000304	0.000304	CcSEcCtD
Cidofovir—Dry mouth—Doxorubicin—testicular cancer	0.000302	0.000302	CcSEcCtD
Cidofovir—Dyspepsia—Methotrexate—testicular cancer	0.000301	0.000301	CcSEcCtD
Cidofovir—Hypotension—Epirubicin—testicular cancer	0.000299	0.000299	CcSEcCtD
Cidofovir—Confusional state—Doxorubicin—testicular cancer	0.000299	0.000299	CcSEcCtD
Cidofovir—Decreased appetite—Methotrexate—testicular cancer	0.000297	0.000297	CcSEcCtD
Cidofovir—Anaphylactic shock—Doxorubicin—testicular cancer	0.000296	0.000296	CcSEcCtD
Cidofovir—Oedema—Doxorubicin—testicular cancer	0.000296	0.000296	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000295	0.000295	CcSEcCtD
Cidofovir—Infection—Doxorubicin—testicular cancer	0.000294	0.000294	CcSEcCtD
Cidofovir—Pain—Methotrexate—testicular cancer	0.000292	0.000292	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000292	0.000292	CcSEcCtD
Cidofovir—Shock—Doxorubicin—testicular cancer	0.000291	0.000291	CcSEcCtD
Cidofovir—Nervous system disorder—Doxorubicin—testicular cancer	0.00029	0.00029	CcSEcCtD
Cidofovir—Thrombocytopenia—Doxorubicin—testicular cancer	0.00029	0.00029	CcSEcCtD
Cidofovir—Insomnia—Epirubicin—testicular cancer	0.000289	0.000289	CcSEcCtD
Cidofovir—Tachycardia—Doxorubicin—testicular cancer	0.000289	0.000289	CcSEcCtD
Cidofovir—Skin disorder—Doxorubicin—testicular cancer	0.000288	0.000288	CcSEcCtD
Cidofovir—Paraesthesia—Epirubicin—testicular cancer	0.000287	0.000287	CcSEcCtD
Cidofovir—Hyperhidrosis—Doxorubicin—testicular cancer	0.000286	0.000286	CcSEcCtD
Cidofovir—Dyspnoea—Epirubicin—testicular cancer	0.000285	0.000285	CcSEcCtD
Cidofovir—Somnolence—Epirubicin—testicular cancer	0.000285	0.000285	CcSEcCtD
Cidofovir—Anorexia—Doxorubicin—testicular cancer	0.000282	0.000282	CcSEcCtD
Cidofovir—Feeling abnormal—Methotrexate—testicular cancer	0.000282	0.000282	CcSEcCtD
Cidofovir—Dyspepsia—Epirubicin—testicular cancer	0.000282	0.000282	CcSEcCtD
Cidofovir—Gastrointestinal pain—Methotrexate—testicular cancer	0.00028	0.00028	CcSEcCtD
Cidofovir—Decreased appetite—Epirubicin—testicular cancer	0.000278	0.000278	CcSEcCtD
Cidofovir—Hypotension—Doxorubicin—testicular cancer	0.000277	0.000277	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000276	0.000276	CcSEcCtD
Cidofovir—Pain—Epirubicin—testicular cancer	0.000274	0.000274	CcSEcCtD
Cidofovir—Constipation—Epirubicin—testicular cancer	0.000274	0.000274	CcSEcCtD
Cidofovir—Urticaria—Methotrexate—testicular cancer	0.000272	0.000272	CcSEcCtD
Cidofovir—Abdominal pain—Methotrexate—testicular cancer	0.00027	0.00027	CcSEcCtD
Cidofovir—Body temperature increased—Methotrexate—testicular cancer	0.00027	0.00027	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00027	0.00027	CcSEcCtD
Cidofovir—Insomnia—Doxorubicin—testicular cancer	0.000268	0.000268	CcSEcCtD
Cidofovir—Paraesthesia—Doxorubicin—testicular cancer	0.000266	0.000266	CcSEcCtD
Cidofovir—Dyspnoea—Doxorubicin—testicular cancer	0.000264	0.000264	CcSEcCtD
Cidofovir—Feeling abnormal—Epirubicin—testicular cancer	0.000264	0.000264	CcSEcCtD
Cidofovir—Somnolence—Doxorubicin—testicular cancer	0.000263	0.000263	CcSEcCtD
Cidofovir—Gastrointestinal pain—Epirubicin—testicular cancer	0.000262	0.000262	CcSEcCtD
Cidofovir—Dyspepsia—Doxorubicin—testicular cancer	0.000261	0.000261	CcSEcCtD
Cidofovir—Decreased appetite—Doxorubicin—testicular cancer	0.000257	0.000257	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000256	0.000256	CcSEcCtD
Cidofovir—Urticaria—Epirubicin—testicular cancer	0.000254	0.000254	CcSEcCtD
Cidofovir—Pain—Doxorubicin—testicular cancer	0.000253	0.000253	CcSEcCtD
Cidofovir—Constipation—Doxorubicin—testicular cancer	0.000253	0.000253	CcSEcCtD
Cidofovir—Abdominal pain—Epirubicin—testicular cancer	0.000253	0.000253	CcSEcCtD
Cidofovir—Body temperature increased—Epirubicin—testicular cancer	0.000253	0.000253	CcSEcCtD
Cidofovir—Hypersensitivity—Methotrexate—testicular cancer	0.000252	0.000252	CcSEcCtD
Cidofovir—Asthenia—Methotrexate—testicular cancer	0.000245	0.000245	CcSEcCtD
Cidofovir—Feeling abnormal—Doxorubicin—testicular cancer	0.000244	0.000244	CcSEcCtD
Cidofovir—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000242	0.000242	CcSEcCtD
Cidofovir—Pruritus—Methotrexate—testicular cancer	0.000242	0.000242	CcSEcCtD
Cidofovir—Hypersensitivity—Epirubicin—testicular cancer	0.000236	0.000236	CcSEcCtD
Cidofovir—Urticaria—Doxorubicin—testicular cancer	0.000235	0.000235	CcSEcCtD
Cidofovir—Abdominal pain—Doxorubicin—testicular cancer	0.000234	0.000234	CcSEcCtD
Cidofovir—Body temperature increased—Doxorubicin—testicular cancer	0.000234	0.000234	CcSEcCtD
Cidofovir—Diarrhoea—Methotrexate—testicular cancer	0.000234	0.000234	CcSEcCtD
Cidofovir—Asthenia—Epirubicin—testicular cancer	0.00023	0.00023	CcSEcCtD
Cidofovir—Pruritus—Epirubicin—testicular cancer	0.000226	0.000226	CcSEcCtD
Cidofovir—Dizziness—Methotrexate—testicular cancer	0.000226	0.000226	CcSEcCtD
Cidofovir—Diarrhoea—Epirubicin—testicular cancer	0.000219	0.000219	CcSEcCtD
Cidofovir—Hypersensitivity—Doxorubicin—testicular cancer	0.000218	0.000218	CcSEcCtD
Cidofovir—Vomiting—Methotrexate—testicular cancer	0.000217	0.000217	CcSEcCtD
Cidofovir—Rash—Methotrexate—testicular cancer	0.000216	0.000216	CcSEcCtD
Cidofovir—Dermatitis—Methotrexate—testicular cancer	0.000215	0.000215	CcSEcCtD
Cidofovir—Headache—Methotrexate—testicular cancer	0.000214	0.000214	CcSEcCtD
Cidofovir—Asthenia—Doxorubicin—testicular cancer	0.000212	0.000212	CcSEcCtD
Cidofovir—Dizziness—Epirubicin—testicular cancer	0.000212	0.000212	CcSEcCtD
Cidofovir—Pruritus—Doxorubicin—testicular cancer	0.00021	0.00021	CcSEcCtD
Cidofovir—Vomiting—Epirubicin—testicular cancer	0.000203	0.000203	CcSEcCtD
Cidofovir—Nausea—Methotrexate—testicular cancer	0.000203	0.000203	CcSEcCtD
Cidofovir—Diarrhoea—Doxorubicin—testicular cancer	0.000203	0.000203	CcSEcCtD
Cidofovir—Rash—Epirubicin—testicular cancer	0.000202	0.000202	CcSEcCtD
Cidofovir—Dermatitis—Epirubicin—testicular cancer	0.000202	0.000202	CcSEcCtD
Cidofovir—Headache—Epirubicin—testicular cancer	0.000201	0.000201	CcSEcCtD
Cidofovir—Dizziness—Doxorubicin—testicular cancer	0.000196	0.000196	CcSEcCtD
Cidofovir—Nausea—Epirubicin—testicular cancer	0.00019	0.00019	CcSEcCtD
Cidofovir—Vomiting—Doxorubicin—testicular cancer	0.000188	0.000188	CcSEcCtD
Cidofovir—Rash—Doxorubicin—testicular cancer	0.000187	0.000187	CcSEcCtD
Cidofovir—Dermatitis—Doxorubicin—testicular cancer	0.000187	0.000187	CcSEcCtD
Cidofovir—Headache—Doxorubicin—testicular cancer	0.000186	0.000186	CcSEcCtD
Cidofovir—Nausea—Doxorubicin—testicular cancer	0.000176	0.000176	CcSEcCtD
